Fermented Cholesterol Lowering Drug (Lovastatin)
Autor: | Anwer Bukhari, Shazia Javed, Sadia Meraj, Munazzah |
---|---|
EAN: | 9783845475158 |
Sachgruppe: | Biologie |
Sprache: | Englisch |
Seitenzahl: | 104 |
Produktart: | Kartoniert / Broschiert |
Veröffentlichungsdatum: | 10.10.2013 |
54,90 €*
Die Verfügbarkeit wird nach ihrer Bestellung bei uns geprüft.
Bücher sind in der Regel innerhalb von 1-2 Werktagen abholbereit.
Lovastatin is an inhibitor of 3-hydroxy-3methylglutaryl-coenzyme A reductase (HMG-CoA reductase), an enzyme that catalyzes the conversion of HMG-CoA to mevalonate. In western countries, the most significant cause of death is the coronary heart disease and progression of atherosclerosis which is mostly related to the hypercholesterolemia. Approximately 10.8% of all deaths are caused due to this disease. Coronary heart disease actually is a wide assortment of diseases. It has been reported that 30 million people have familial hypercholesterolemia worldwide, but less than 1% of cases are diagnosed in most countries. A lab experiment was carried out for fungal production of lovastatin in solid state fermentation. Fermentation medium was optimized by optimizing the fermentation parameters (pH, temperature, inoculum size, moisture contents etc.).